Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
६०८.७७६०८.७७६१२.९७६०८.७७
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
६४२.५८६४४.८७६४८.४८६४०.१८
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
८५१.१३८५५.६६८५८.७५८४५.५६
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
२१७.९८२१७.९८२१८.६५२१६.८८
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
९४८.९८९४८.५८९५७.८३९४१.९७
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२
MYD:FRA
Myriad Genetics Inc
€ ३.९५
-३.१६%
(-०.१३) 1D
अप्रिल ३०, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MYD...
Open
€ ३.९५
High
€ ३.९५
Low
€ ३.९५
Mkt. cap
४५.३३ करोड
Avg. vol.
३५९.००
Volume
०.००
52-wk high
€ ७.१०
52-wk low
€ ३.३०
No. of employees
३ हजार
News stories
From sources across the web
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees२.७ हजार
Founded१९९१
Headquartersसाल्ट लेक सिटी, युटा, संयुक्त राज्य अमेरिका
Sector-
Websitemyriad.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
१९.५९ करोड
२१.३१ करोड
२०.५७ करोड
२०.९८ करोड
Cost of goods sold
६.१७ करोड
६.१३ करोड
६.१९ करोड
६.३० करोड
Cost of revenue
६.१७ करोड
६.१३ करोड
६.१९ करोड
६.३० करोड
Research and development expenses
२.७५ करोड
२.५६ करोड
२.८२ करोड
२.५५ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१३.५७ करोड
१३.८७ करोड
१३.८९ करोड
१२.४३ करोड
Operating expense
१६.३२ करोड
१६.४३ करोड
१६.७१ करोड
१४.९८ करोड
Total operating expenses
२२.४९ करोड
२२.५६ करोड
२२.९० करोड
२१.२८ करोड
Operating income
-२.९० करोड
-१.२५ करोड
-२.३३ करोड
-३०.०० लाख
Other non operating income
१.०० लाख
-१.०० लाख
४.०० लाख
४.०० लाख
EBT including unusual items
-२.९४ करोड
-३३.०६ करोड
-२.६२ करोड
-८९.०० लाख
EBT excluding unusual items
-२.९४ करोड
-१.३९ करोड
-२.६२ करोड
-६२.०० लाख
Income tax expense
-२.९३ करोड
-१.०० लाख
१२.०० लाख
-१०.०० लाख
Effective tax rate
९९.६६%
०.०३%
-४.५८%
११.२४%
Other operating expenses
-
-
-
-
Net income
-१.०० लाख
-३३.०५ करोड
-२.७४ करोड
-७९.०० लाख
Net profit margin
-०.०५%
-१५५.०९%
-१३.३२%
-३.७७%
Earnings per share
-०.०३
०.०५
-
०.०४
Interest and investment income
३.०० लाख
२.०० लाख
५.०० लाख
८.०० लाख
Interest expense
-८.०० लाख
-१५.०० लाख
-३८.०० लाख
-४४.०० लाख
Net interest expenses
-५.०० लाख
-१३.०० लाख
-३३.०० लाख
-३६.०० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.४६ करोड
१६.०० लाख
-१.०७ करोड
९६.०० लाख
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more